Literature DB >> 16454655

Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer.

David M Lubaroff1, Badrinath Konety, Brian K Link, Timothy L Ratliff, Tammy Madsen, Mary Shannon, Dixie Ecklund, Richard D Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454655     DOI: 10.1089/hum.2006.17.220

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  7 in total

1.  Vaccine immunotherapy for prostate cancer: from mice to men.

Authors:  David M Lubaroff; Daniel Vaena; James A Brown; Pamela Zehr; Karen C Griffith; Erica Brown; Julie Eastman; Kenneth Nepple; Ambika Kattula; Richard D Williams
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 2.  Role of Adenoviruses in Cancer Therapy.

Authors:  Sintayehu Tsegaye Tseha
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

3.  Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results.

Authors:  David M Lubaroff; Badrinath R Konety; Brian Link; Jack Gerstbrein; Tammy Madsen; Mary Shannon; Jeanne Howard; Jennifer Paisley; Diana Boeglin; Timothy L Ratliff; Richard D Williams
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

Review 4.  Proposed mechanisms of action for prostate cancer vaccines.

Authors:  Sean M Geary; Caitlin D Lemke; David M Lubaroff; Aliasger K Salem
Journal:  Nat Rev Urol       Date:  2013-02-12       Impact factor: 14.432

Review 5.  Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination.

Authors:  Mizuho Sato-Dahlman; Christopher J LaRocca; Chikako Yanagiba; Masato Yamamoto
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

6.  Prostate cancer vaccines: Update on clinical development.

Authors:  Sean M Geary; Aliasger K Salem
Journal:  Oncoimmunology       Date:  2013-04-29       Impact factor: 7.723

Review 7.  Prostate cancer vaccines in combination with additional treatment modalities.

Authors:  Matthew A Uhlman; Megan T Bing; David M Lubaroff
Journal:  Immunol Res       Date:  2014-08       Impact factor: 4.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.